These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33501747)

  • 1. Ribosome-targeting antibacterial agents: Advances, challenges, and opportunities.
    Zhang L; He J; Bai L; Ruan S; Yang T; Luo Y
    Med Res Rev; 2021 Jul; 41(4):1855-1889. PubMed ID: 33501747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial Protein Synthesis as a Target for Antibiotic Inhibition.
    Arenz S; Wilson DN
    Cold Spring Harb Perspect Med; 2016 Sep; 6(9):. PubMed ID: 27481773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of recent improvements in cryo-electron microscopy technology on the understanding of bacterial ribosome assembly.
    Razi A; Britton RA; Ortega J
    Nucleic Acids Res; 2017 Feb; 45(3):1027-1040. PubMed ID: 28180306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct visualization of ribosomes in the cell-free system revealed the functional evolution of aminoglycoside.
    Tomono J; Asano K; Chiashi T; Suzuki M; Igarashi M; Takahashi Y; Tanaka Y; Yokoyama T
    J Biochem; 2024 May; 175(6):587-598. PubMed ID: 38227611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects for antimicrobial development in the cryo-EM era - a focus on the ribosome.
    Herrero Del Valle A; Innis CA
    FEMS Microbiol Rev; 2020 Nov; 44(6):793-803. PubMed ID: 32717057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the 70S Ribosome from the Human Pathogen Acinetobacter baumannii in Complex with Clinically Relevant Antibiotics.
    Nicholson D; Edwards TA; O'Neill AJ; Ranson NA
    Structure; 2020 Oct; 28(10):1087-1100.e3. PubMed ID: 32857965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the Human 80S Ribosome in Cancer: From Structure to Function and Drug Design for Innovative Adjuvant Therapeutic Strategies.
    Gilles A; Frechin L; Natchiar K; Biondani G; Loeffelholz OV; Holvec S; Malaval JL; Winum JY; Klaholz BP; Peyron JF
    Cells; 2020 Mar; 9(3):. PubMed ID: 32151059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design.
    Lin J; Zhou D; Steitz TA; Polikanov YS; Gagnon MG
    Annu Rev Biochem; 2018 Jun; 87():451-478. PubMed ID: 29570352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Numbers Game: Ribosome Densities, Bacterial Growth, and Antibiotic-Mediated Stasis and Death.
    Levin BR; McCall IC; Perrot V; Weiss H; Ovesepian A; Baquero F
    mBio; 2017 Feb; 8(1):. PubMed ID: 28174311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The WblC/WhiB7 Transcription Factor Controls Intrinsic Resistance to Translation-Targeting Antibiotics by Altering Ribosome Composition.
    Lee JH; Yoo JS; Kim Y; Kim JS; Lee EJ; Roe JH
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bacterial ribosome, a promising focus for structure-based drug design.
    Knowles DJ; Foloppe N; Matassova NB; Murchie AI
    Curr Opin Pharmacol; 2002 Oct; 2(5):501-6. PubMed ID: 12324250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focused classification and refinement in high-resolution cryo-EM structural analysis of ribosome complexes.
    von Loeffelholz O; Natchiar SK; Djabeur N; Myasnikov AG; Kratzat H; Ménétret JF; Hazemann I; Klaholz BP
    Curr Opin Struct Biol; 2017 Oct; 46():140-148. PubMed ID: 28850874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribosome-targeting antibiotics and mechanisms of bacterial resistance.
    Wilson DN
    Nat Rev Microbiol; 2014 Jan; 12(1):35-48. PubMed ID: 24336183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blast from the Past: Reassessing Forgotten Translation Inhibitors, Antibiotic Selectivity, and Resistance Mechanisms to Aid Drug Development.
    Arenz S; Wilson DN
    Mol Cell; 2016 Jan; 61(1):3-14. PubMed ID: 26585390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting the Nucleoside Antibiotics as Universal Translation Inhibitors.
    Nelli MR; Heitmeier KN; Looper RE
    Acc Chem Res; 2021 Jul; 54(13):2798-2811. PubMed ID: 34152729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whither Ribosome Structure and Dynamics Research? (A Perspective).
    Frank J
    J Mol Biol; 2016 Sep; 428(18):3565-9. PubMed ID: 27178840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the improved macrolide inhibitory activity from the high-resolution cryo-EM structure of dirithromycin bound to the
    Pichkur EB; Paleskava A; Tereshchenkov AG; Kasatsky P; Komarova ES; Shiriaev DI; Bogdanov AA; Dontsova OA; Osterman IA; Sergiev PV; Polikanov YS; Myasnikov AG; Konevega AL
    RNA; 2020 Jun; 26(6):715-723. PubMed ID: 32144191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translation machinery captured in motion.
    Zafar H; Hassan AH; Demo G
    Wiley Interdiscip Rev RNA; 2023; 14(5):e1792. PubMed ID: 37132456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the E. coli ribosome-EF-Tu complex at <3 Å resolution by Cs-corrected cryo-EM.
    Fischer N; Neumann P; Konevega AL; Bock LV; Ficner R; Rodnina MV; Stark H
    Nature; 2015 Apr; 520(7548):567-70. PubMed ID: 25707802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for selectivity and toxicity of ribosomal antibiotics.
    Böttger EC; Springer B; Prammananan T; Kidan Y; Sander P
    EMBO Rep; 2001 Apr; 2(4):318-23. PubMed ID: 11306553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.